MedTrace Logo

Omega 7 + 3 Combination and Systemic Inflammation

NCT02155816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2015-07-16

No results posted yet for this study

Summary

The purpose of this study is to determine if supplementation with a mixture of omega 7 and 3 fats has a favorable influence on blood inflammation and lipoprotein biomarkers in women with systemic inflammation compared to omega 3 and placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega 7 + 3

Ingestion of omega 7 + 3 daily for 8 weeks.

DIETARY_SUPPLEMENT

Omega 3

Omega 3 daily for 8 weeks.

DIETARY_SUPPLEMENT

Placebo

Medium chain triglycerides

Sponsors & Collaborators

  • Appalachian State University

    lead OTHER

Principal Investigators

  • David Nieman, DrPH · Appalachian State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-07-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155816 on ClinicalTrials.gov